| Dr Deanna Macy Louie, MD | |
|
2020 Fleischmann Rd, Tallahassee, FL 32308-4599 | |
| (850) 878-6161 | |
| (850) 626-0200 |
| Full Name | Dr Deanna Macy Louie |
|---|---|
| Gender | Female |
| Speciality | Ophthalmology |
| Experience | 16 Years |
| Location | 2020 Fleischmann Rd, Tallahassee, Florida |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386886141 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | A121476 (California) | Secondary |
| 207W00000X | Ophthalmology | ME128564 (Florida) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Eye Associates Of Tallahassee, P.a. | 7315900370 | 10 |
News Archive
Curis, Inc., announced today that its licensee Debiopharm S.A. has received approval from France's regulatory authority Agence Française de Securité Sanitaire des Produits de Santé (AFSSAPS) of a Clinical Trial Application (CTA) for small molecule heat shock protein 90 (Hsp90) inhibitor Debio 0932, formerly called CUDC-305. Under the terms of Curis' and Debiopharm's August 2009 license agreement, Curis will receive an $8 million milestone payment from Debiopharm for the achievement of this development objective.
Amerigroup Corporation announced its successful efforts at preventing premature births – as well its commitment to protecting access to affordable drug therapies for at-risk mothers – at the annual Norfolk/Virginia Beach March of Dimes kick-off breakfast for the March for Babies.
Hercules Technology Growth Capital, Inc., the leading specialty finance company providing venture debt and equity to venture capital and private equity-backed technology and life science companies at all stages of development, today announced that it has recorded gross realized proceeds on the sale of Gomez, Inc., one of its portfolio companies, to Compuware Corporation of $1.7 million.
A blood test that has shown promise in predicting how cancer will progress and what treatments will be most effective for a given patient may not be reliable for either, according to a new Penn Medicine study published this week in Cancer, a peer-reviewed journal of the American Cancer Society.
Mark R. Katlic, M.D., chief of Surgery at Sinai Hospital of Baltimore, has been selected to receive a 2013 Innovator of the Year award from The Daily Record. He was recognized for his pioneering work as the director of the groundbreaking Sinai Center for Geriatric Surgery.
› Verified 6 days ago
| Entity Name | Eye Associates Of Tallahassee, P.a. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750388203 PECOS PAC ID: 7315900370 Enrollment ID: O20041110000618 |
News Archive
Curis, Inc., announced today that its licensee Debiopharm S.A. has received approval from France's regulatory authority Agence Française de Securité Sanitaire des Produits de Santé (AFSSAPS) of a Clinical Trial Application (CTA) for small molecule heat shock protein 90 (Hsp90) inhibitor Debio 0932, formerly called CUDC-305. Under the terms of Curis' and Debiopharm's August 2009 license agreement, Curis will receive an $8 million milestone payment from Debiopharm for the achievement of this development objective.
Amerigroup Corporation announced its successful efforts at preventing premature births – as well its commitment to protecting access to affordable drug therapies for at-risk mothers – at the annual Norfolk/Virginia Beach March of Dimes kick-off breakfast for the March for Babies.
Hercules Technology Growth Capital, Inc., the leading specialty finance company providing venture debt and equity to venture capital and private equity-backed technology and life science companies at all stages of development, today announced that it has recorded gross realized proceeds on the sale of Gomez, Inc., one of its portfolio companies, to Compuware Corporation of $1.7 million.
A blood test that has shown promise in predicting how cancer will progress and what treatments will be most effective for a given patient may not be reliable for either, according to a new Penn Medicine study published this week in Cancer, a peer-reviewed journal of the American Cancer Society.
Mark R. Katlic, M.D., chief of Surgery at Sinai Hospital of Baltimore, has been selected to receive a 2013 Innovator of the Year award from The Daily Record. He was recognized for his pioneering work as the director of the groundbreaking Sinai Center for Geriatric Surgery.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Deanna Macy Louie, MD 2020 Fleischmann Rd, Tallahassee, FL 32308-4599 Ph: (850) 878-6161 | Dr Deanna Macy Louie, MD 2020 Fleischmann Rd, Tallahassee, FL 32308-4599 Ph: (850) 878-6161 |
News Archive
Curis, Inc., announced today that its licensee Debiopharm S.A. has received approval from France's regulatory authority Agence Française de Securité Sanitaire des Produits de Santé (AFSSAPS) of a Clinical Trial Application (CTA) for small molecule heat shock protein 90 (Hsp90) inhibitor Debio 0932, formerly called CUDC-305. Under the terms of Curis' and Debiopharm's August 2009 license agreement, Curis will receive an $8 million milestone payment from Debiopharm for the achievement of this development objective.
Amerigroup Corporation announced its successful efforts at preventing premature births – as well its commitment to protecting access to affordable drug therapies for at-risk mothers – at the annual Norfolk/Virginia Beach March of Dimes kick-off breakfast for the March for Babies.
Hercules Technology Growth Capital, Inc., the leading specialty finance company providing venture debt and equity to venture capital and private equity-backed technology and life science companies at all stages of development, today announced that it has recorded gross realized proceeds on the sale of Gomez, Inc., one of its portfolio companies, to Compuware Corporation of $1.7 million.
A blood test that has shown promise in predicting how cancer will progress and what treatments will be most effective for a given patient may not be reliable for either, according to a new Penn Medicine study published this week in Cancer, a peer-reviewed journal of the American Cancer Society.
Mark R. Katlic, M.D., chief of Surgery at Sinai Hospital of Baltimore, has been selected to receive a 2013 Innovator of the Year award from The Daily Record. He was recognized for his pioneering work as the director of the groundbreaking Sinai Center for Geriatric Surgery.
› Verified 6 days ago
Dr. Joel H Kramer, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 1401 Centerville Rd, Suite 404, Tallahassee, FL 32308 Phone: 850-385-2095 Fax: 850-656-2255 | |
Dr. Robert L Steinmetz, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2439 Care Dr, Tallahassee, FL 32308 Phone: 850-942-6700 Fax: 850-942-5735 | |
Fang Sarah Ko, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2020 Fleischmann Rd, Tallahassee, FL 32308 Phone: 850-878-6161 Fax: 850-656-0200 | |
Dr. Richard Mark Palmer, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 2535 Capital Medical Blvd, Tallahassee, FL 32308 Phone: 850-877-7337 Fax: 850-877-8675 | |
Dr. Charles K Newell, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2439 Care Dr, Tallahassee, FL 32308 Phone: 850-942-6700 Fax: 850-942-5735 | |
Dr. Nicholas Craig Farber, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2349 Care Drive, Tallahassee, FL 32308 Phone: 850-942-6700 |